Cargando…
THU555 Stress Induced AIPB Expression In Triple Negative (ER-/PR-/Her2-) Breast Tumors Reduces Estradiol
Disclosure: M. Patrawala: None. H.S. Bose: None. In the United States, 1 in 8 women will develop invasive breast cancer in their lifetimes, and currently, more than 3.8 million individuals are survivors. Breast cancers are hormonally regulated and are categorized ER+/PR+/HER2-, ER-/PR-/HER2+, ER+/PR...
Autores principales: | Patrawala, Mahjabin, Bose, Himangshu S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553867/ http://dx.doi.org/10.1210/jendso/bvad114.2181 |
Ejemplares similares
-
ODP539 AIPB is a Biomarker for ER+/PR+/Her2- Breast Cancers
por: Cubbedge, Chandler, et al.
Publicado: (2022) -
ODP433 An increased in AIPB expression in Triple Negative (ER-/PR-/Her2-) Breast Tumors reduces estradiol synthesis
por: Downs, William V, et al.
Publicado: (2022) -
ODP540 Aromatase interacting partner in Breast (AIPB) regulates estradiol in human breast
por: Moffitt, Alyssa M, et al.
Publicado: (2022) -
FRI407 Identification Of AIPB Expression For Early Breast Cancer Prediction
por: Doetch, Nicole Elizabeth, et al.
Publicado: (2023) -
THU489 The Role Of Noncoding Genes With The Bidirectional Promoter In Triple-negative Breast Cancer
por: Yang, Barbara, et al.
Publicado: (2023)